TAM
MPLT

TFG Asset Management’s MapLight Therapeutics MPLT Stock Holding History

TFG Asset Management’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,115
Closed -$2.28M – 46
2026
Q1 		$2.28M Sell
112,115
-52,410
-32% -$937K 0.44% 29
2025
Q4 		$2.89M Buy
+164,525
New +$2.76M 0.61% 24

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TFG Asset Management's MPLT Position: Q2 2026 in Review

TFG Asset Management sold out of MapLight Therapeutics (MPLT) in Q2 2026, closing a stake of 112,115 shares — an estimated $2.28M sold.

TFG Asset Management first reported a position in MPLT in Q4 2025 and held it in 2 quarters. The position peaked at $2.89M in Q4 2025. 106 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • TFG Asset Management reported no remaining MapLight Therapeutics position as of Q2 2026 after selling out during the quarter.
  • TFG Asset Management sold 112,115 MapLight Therapeutics shares in Q2 2026, an estimated $2.28M.
  • TFG Asset Management first reported a position in MapLight Therapeutics in Q4 2025 and held it in 2 quarters.
  • TFG Asset Management's MapLight Therapeutics position peaked at $2.89M in Q4 2025.
  • 106 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.